According to bioinformatics, it was found that miR-138 and SEMA4C have predicted binding sites, and studies [12] have shown that miR-139 targeting SEMA4C can affect the epithelial-mesenchymal transition of non-small cell lung cancer cells. Here, SEMA4C is linked to non-small cell lung carcinoma.